Therapeutic Plasma Exchange
5
0
0
4
Key Insights
Highlights
Success Rate
80% trial completion
Treatment Research
7 treatments under study, led by Therapeutic Plasma Exchange Tpe
Research Leaders
5 sponsors active, led by University of Alabama at Birmingham
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
20.0%
1 terminated out of 5 trials
80.0%
-6.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (5)
RescuE pLAsma eXchange in Severe COVID-19
Comparison Between Centrifugation Based and Membrane Based Plasma Exchange
Evaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation
TPE in Rennes Hospital
IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES.
Research Network
Common Treatments
- Therapeutic Plasma Exchange Tpe1
- Active Comparator Filter Tpe With Heparin1
- Active Comparator Filter Tpe With Citrate1
- Active Comparator Centrifuge Tpe With Citrate1
- Evolution Of Antibodies Titre1
Active Sponsors
- University of Alabama at Birmingham1
- Alexandria University1
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
- Heidelberg University1
- Rennes University Hospital1
Top Investigators
Rennes University Hospital
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Department of internal medicine, nephrology unit, Alexandria faculty of medicine, Egypt
University of Alabama at Birmingham
Related Conditions
- Covid191
- Anticoagulant Therapy1